Delivery Order SPE2DB24D1021-SPE2DB25FEXUT
Award Date
6/17/25
Potential Completion Date
6/18/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Actemra 162 mg/0.9 ml syringes. The award, valued at $2,035.59, is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Actemra 162 mg/0.9 ml syringes. The contract has a firm fixed price of $6,090.04 and a period of performance through April 29, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Actemra 162 mg/0.9 mL syringes. The contract has a ceiling value of $11,920.65 and a period of performance through May 12, 2025. It is a firm-fixed-price contract, meaning the price is predetermined and not subject to adjustment. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Actemra 162 mg/0.9 ml syringes, with a ceiling value of $6,744.15 and a period of performance through February 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Actemra 162 mg/0.9 ml syringes. The contract has a firm fixed price, with a ceiling value of $12,495.31, and an ultimate completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,634.81, is for the supply of the drug Actemra (162 mg/0.9 ml syringe). The award has an ultimate completion date of April 15, 2025. This contract is not a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,943.04 and covers the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML, a pharmaceutical product, through February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The contract has a firm fixed price, with a ceiling value of $8,322.43 and a period of performance through January 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,084.10, is for the delivery of 400 mg/20 ml vials of the medication Actemra. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Actemra (tocilizumab) 162 mg/0.9 mL syringes. The contract is a firm fixed-price delivery order with a ceiling value of $5,755.68 and a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...